universita' degli studi di milano - Alessandro Guerini Rocco

77. Inadera, H., T. Sekiya, T. Yoshimura, and K. Matsushima, Molecular analisis
of the inhibition of monocyte chemoattractant protein-1 gene expression by
estrogen and xenoestrogen in MCF-7. Endocrinology, 2000. 141: p. 50-9.
78. Kanda, N. and S. Watanabe, 17beta-estradiol inhibits the production of RAN-
TES in human keratinocytes. J Invest Dermatol, 2003. 120(3): p. 420-7.
79. Gaub, M.P., M. Bellard, I. Scheuer, P. Chambon, and P. Sassone-Corsi, Activation
of the ovalbumin gene by the estrogen receptor involves the fos-jun
complex. Cell, 1990. 63(6): p. 1267-76.
80. Philips, A., D. Chalbos, and H. Rochefort, Estradiol increases and anti-estrogens
antagonize the growth factor-induced activator protein-1 activity in
MCF7 breast cancer cells without affecting c-fos and c-jun synthesis. J Biol
Chem, 1993. 268(19): p. 14103-8.
81. Srivastava, S., M.N. Weitzmann, S. Cenci, F.P. Ross, S. Adler, and R. Pacifici,
Estrogen decreases TNF gene expression by blocking JNK activity and the resulting
production of c-Jun and JunD. J Clin Invest, 1999. 104(4): p. 503-13.
82. An, J., R.C. Ribeiro, P. Webb, J.A. Gustafsson, P.J. Kushner, J.D. Baxter, and
D.C. Leitman, Estradiol repression of tumor necrosis factor-alpha transcription
requires estrogen receptor activation function-2 and is enhanced by coactivators.
Proc Natl Acad Sci U S A, 1999. 96(26): p. 15161-6.
83. Kanda, N. and S. Watanabe, 17Beta-estradiol inhibits MCP-1 production in
human keratinocytes. J Invest Dermatol, 2003. 120(6): p. 1058-66.
84. Galea, E., R. Santizo, D.L. Feinstein, P. Adamsom, J. Greenwood, H.M. Koenig,
and D.A. Pelligrino, Estrogen inhibits NF kappa B-dependent inflammation
in brain endothelium without interfering with I kappa B degradation. Neuroreport,
2002. 13(11): p. 1469-72.
85. Caulin-Glaser, T., C.A. Watson, R. Pardi, and J.R. Bender, Effects of 17betaestradiol
on cytokine-induced endothelial cell adhesion molecule expression. J
Clin Invest, 1996. 98(1): p. 36-42.
86. Sun, G., W. Porter, and S. Safe, Estrogen-induced retinoic acid receptor -Sp-1
complex. Mol Endocrinol, 1998. 12: p. 882-90.
87. Porter, W., B. Saville, D. Hoivik, and S. Safe, Functional synergy between the
transcription factor Sp1 and the estrogen receptor. Mol Endocrinol, 1999. 11:
p. 1569-80.
88. Kelly, M.J., R.L. Moss, and C.A. Dudley, Differential sensitivity of preopticseptal
neurons to microelectrophoresed estrogen during the estrous cycle.
Brain Res, 1976. 114(1): p. 152-7.
89. Pietras, R.J. and C.M. Szego, Specific binding sites for estrogen at the outer
surfaces of isolated endometrial cells. Nature, 1977. 265: p. 69-72.
90. Pietras, R.J. and C.M. Szego, Partial purification and characterization of oestrogen
receptors in subfractions of hepatocyte plasma membranes. Biochem
J, 1980. 191(3): p. 743-60.
91. Levin, E.R., Cellular functions of plasma membrane estrogen receptors. Steroids,
2002. 67(6): p. 471-5.
92. Maggi, A., P. Ciana, S. Belcredito, and E. Vegeto, Estrogens in the nervous
system: mechanisms and nonreproductive functions. Annu Rev Physiol, 2004.
66: p. 291-313.
93. Simoncini, T., L. Fornari, P. Mannella, G. Varone, A. Caruso, J.K. Liao, and
A.R. Genazzani, Novel non-transcriptional mechanism for estrogen receptor
128